Webinars 2015

Hepatitis B and Liver Cancer Connections

In this interactive session, you will learn more about the link between viral hepatitis and liver cancer, liver cancer prevention programs and resources, and how you can get involved in an upcoming awareness campaign.

Presentation Slides:
Hepatitis B and Liver Cancer Connections; Anu Hosangadi
Think About the Link; Kennesha Baldwin

Global Movement to Eliminate Viral Hepatitis

Worldwide, more than 400 million people are living with chronic hepatitis B and C infection and more than 1.4 million people die each year from liver disease and liver cancer caused by hepatitis B and C. This webinar discusses global strategies to eliminate viral hepatitis including outcomes from the 2015 World Hepatitis Summit, new global hepatitis guidelines and resources, and information on how you can get involved in the global movement to combat viral hepatitis.

Presentation Slides:
Viral Hepatitis Advocacy; Charles Gore
World Hepatitis Alliance: The Americas Region; Su Wang

CDC’s Enhanced Viral Hepatitis Surveillance Programs

In 2012, the Centers for Disease Control and Prevention’s Division of Viral Hepatitis funded sites across the U.S. to conduct enhanced surveillance for viral hepatitis. Enhanced surveillance involves the collection of more extensive and complete information than is possible through the current national surveillance system. This interactive session showcases state and local epidemiologists who share their experiences and findings from enhanced hepatitis B surveillance in Michigan and Philadelphia.

Presentation Slides:
CDC’s NCHHSTP: Division of Viral Hepatitis; Henry Roberts
Viral Hepatitis Surveillance Activities at the Philadelphia Department of Public Health; Kendra Viner
Hepatitis B Virus Surveillance and Epidemiology in Michigan; Joe Coyle

The Asian American Hepatitis B Story: What We Know and What We Can Do

Watch this interactive session as expert panelists working on hepatitis B and liver cancer research discuss strategies for addressing hepatitis B among Asian Americans and Pacific Islanders. Topics include the latest research on and tools (including the use of “photonovels”) for controlling hepatitis B, overcoming barriers, improving knowledge, and controlling hepatitis B among Asian Americans.

Presentation Slides:
Culturally Integrated Educational Material; Hee-Soon Juon
Prevalence, Progress, and Prospects for Control; Moon S. Chen & Julie Dang

Viral Hepatitis Preventive Services and the Affordable Care Act

Watch this interactive session to learn more about implementation of the USPSTF hepatitis screening recommendations and what this means for viral hepatitis preventive services under the Affordable Care Act. Panelists discuss successes to date, opportunities, and how you can get involved.

Presentation Slides:
ACA and the Viral Hepatitis Preventive Services Successes, Challenges, and Opportunities; Ryan Clary
CDC’s Role in Implementing Viral Hepatitis Preventive Services; Deborah Holtzman
Strategies in Implementing USPSTF Hepatitis B Screening Recommendations; Isha Weerasinghe

Living with Hepatitis B – Cultural Barriers, Stigma, and Institutional Discrimination

Watch this interactive session to learn more about overcoming hepatitis B-related stigma and discrimination. Speakers discuss cultural barriers unique to AAPI communities, cases of hepatitis B-related discrimination, and protection of the rights of individuals living with hepatitis B under the Americans with Disabilities Act.

Presentation Slides:
Hepatitis B Stigma and Discrimination; Joan Block
Barriers, Stigma, and Discrimination; Nadine Shiroma
Hepatitis B and the ADA; Susana Lorenzo-Giguere